Nutrient Supplementation: Improving Male Fertility Fourfold

Cesar Mora-Esteves; David Shin

doi:10.1055/s-0033-1345277

Seminars in Reproductive Medicine, Table of Contents

Semin Reprod Med 2013; 31(04): 293-300
DOI: 10.1055/s-0033-1345277

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Nutrient Supplementation: Improving Male Fertility Fourfold

Authors

Cesar Mora-Esteves

¹Division of Urology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey
David Shin

²Department of Urology, Hackensack University Medical Center, Hackensack, New Jersey

Abstract

Oxidative stress can contribute to impairment in spermatogenesis leading to male-factor infertility. The effectiveness of various antioxidants (such as carnitine, vitamin C, vitamin E, selenium, carotenoids, glutathione, N-acetylcysteine, zinc, folic acid, and coenzyme Q10) is variable with respect to improving semen parameters and pregnancy rates. A recent Cochrane review determined that men taking antioxidants had a statistically significant increase in both live birth rates and pregnancy rates. For those undergoing assisted reproduction, the odds ratio that antioxidant use would improve pregnancy rates was 4.18, with a 4.85-fold improvement in live birth rate also noted. Further investigation with randomized, controlled clinical trials is needed to confirm the safety and efficacy of antioxidant supplementation in the medical management and treatment of male infertility.

Keywords

male infertility - antioxidant therapy - vitamin supplements - oxidative stress

Full Text

References

References
1 Sharlip ID, Jarow JP, Belker AM , et al. Best practice policies for male infertility. Fertil Steril 2002; 77 (5) 873-882
2 World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. 4th ed. Cambridge: Cambridge University Press; 1999: 1-86
3 Warren JS, Johnson KJ, Ward PA. Oxygen radicals in cell injury and cell death. Pathol Immunopathol Res 1987; 6 (5–6) 301-315
4 Kefer JC, Agarwal A, Sabanegh E. Role of antioxidants in the treatment of male infertility. Int J Urol 2009; 16: 499-57
5 Saleh RA, Agarwal A. Oxidative stress and male infertility: from research bench to clinical practice. J Androl 2002; 23 (6) 737-752
6 Aitken RJ. Free radicals, lipid peroxidation and sperm function. Reprod Fertil Dev 1995; 7 (4) 659-668
7 Baker HW, Brindle J, Irvine DS, Aitken RJ. Protective effect of antioxidants on the impairment of sperm motility by activated polymorphonuclear leukocytes. Fertil Steril 1996; 65 (2) 411-419
8 Mahfouz R, Sharma R, Sharma D, Sabanegh E, Agarwal A. Diagnostic value of the total antioxidant capacity (TAC) in human seminal plasma. Fertil Steril 2009; 91 (3) 805-811
9 Sharma RK, Agarwal A. Role of reactive oxygen species in male infertility. Urology 1996; 48 (6) 835-850
10 Kemal Duru N, Morshedi M, Oehninger S. Effects of hydrogen peroxide on DNA and plasma membrane integrity of human spermatozoa. Fertil Steril 2000; 74 (6) 1200-1207
11 Misro MM, Choudhury L, Upreti K , et al. Use of hydrogen peroxide to assess the sperm susceptibility to oxidative stress in subjects presenting a normal semen profile. Int J Androl 2004; 27 (2) 82-87
12 Sikka SC. Relative impact of oxidative stress on male reproductive function. Curr Med Chem 2001; 8 (7) 851-862
13 Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril 2003; 79 (4) 829-843
14 Sikka SC. Role of oxidative stress and antioxidants in andrology and assisted reproductive technology. J Androl 2004; 25 (1) 5-18
15 Wang X, Sharma RK, Sikka SC, Thomas Jr AJ, Falcone T, Agarwal A. Oxidative stress is associated with increased apoptosis leading to spermatozoa DNA damage in patients with male factor infertility. Fertil Steril 2003; 80 (3) 531-535
16 Bonanomi M, Lucente G, Silvestrini B. Male fertility: core chemical structure in pharmacological research. Contraception 2002; 65 (4) 317-320
17 Tremellen K. Oxidative stress and male infertility—a clinical perspective. Hum Reprod Update 2008; 14 (3) 243-258
18 Bykova M, Athayde K, Sharma R, Jha R, Sabanegh E, Agarwal A. Defining the reference value of seminal reactive oxygen species in a population of infertile men and normal healthy volunteers. Fertil Steril 2007; 88: 305
19 Showell MG, Brown J, Yazdani A, Stankiewics MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev 2011; (1) CD007411
20 Aitken RJ, Koopman P, Lewis SE. Seeds of concern. Nature 2004; 432 (7013) 48-52
21 Tarozzi N, Bizzaro D, Flamigni C, Borini A. Clinical relevance of sperm DNA damage in assisted reproduction. Reprod Biomed Online 2007; 14 (6) 746-757
22 Deepinder F, Cocuzza M, Agarwal A. Should seminal oxidative stress measurement be offered routinely to men presenting for infertility evaluation?. Endocr Pract 2008; 14 (4) 484-491
23 Jeulin C, Lewin LM. Role of free L-carnitine and acetyl-L-carnitine in post-gonadal maturation of mammalian spermatozoa. Hum Reprod Update 1996; 2 (2) 87-102
24 Frenkel RA, Mc Garry JD , eds. Carnitine Biosynthesis, Metabolism and Function. [Italian edition]. New York: Academic Press; 1984: 271-284
25 Peluso G, Nicolai R, Reda E, Benatti P, Barbarisi A, Calvani M. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol 2000; 182 (3) 339-350
26 Vicari E, Calogero AE. Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis. Hum Reprod 2001; 16 (11) 2338-2342
27 Lenzi A, Lombardo F, Sgrò P , et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril 2003; 79 (2) 292-300
28 Gattuccio F, De Rose AF, Latteri MA , eds. Varicocele. Palermo, Italy: Cofese Editore; 2000: 205-210
29 Lenzi A, Sgrò P, Salacone P , et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril 2004; 81 (6) 1578-1584
30 Cavallini G, Ferraretti AP, Gianaroli L, Biagiotti G, Vitali G. Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. J Androl 2004; 25 (5) 761-770 , discussion 771–772
31 Arduini A. Carnitine and its acyl esters as secondary antioxidants?. Am Heart J 1992; 123 (6) 1726-1727
32 Menchini-Fabris GF, Canale D, Izzo PL, Olivieri L, Bartelloni M. Free L-carnitine in human semen: its variability in different andrologic pathologies. Fertil Steril 1984; 42 (2) 263-267
33 Bornman MS, du Toit D, Otto B, Müller II, Hurter P, du Plessis DJ. Seminal carnitine, epididymal function and spermatozoal motility. S Afr Med J 1989; 75 (1) 20-21
34 Johansen L, Bøhmer T. Carnitine-binding related suppressed oxygen uptake by spermatozoa. Arch Androl 1978; 1 (4) 321-324
35 Radigue C, Es-Slami S, Soufir JC. Relationship of carnitine transport across the epididymis to blood carnitine and androgens in rats. Arch Androl 1996; 37 (1) 27-31
36 Golan R, Weissenberg R, Lewin LM. Carnitine and acetylcarnitine in motile and immotile human spermatozoa. Int J Androl 1984; 7: 484-494
37 Bartellini M, Canale D, Izzo PL, Giorgi PM, Meschini P, Mechini-Fabris GF. L-carnitine and acetylcarnitine in human sperm with normal and reduced motility. Acta Eur Fertil 1987; 18 (1) 29-31
38 Costa M, Canale D, Filicori M, D'lddio S, Lenzi A. Italian Study Group on Carnitine and Male Infertility . L-carnitine in idiopathic asthenozoospermia: a multicenter study. Andrologia 1994; 26 (3) 155-159
39 Vitali G, Parente R, Melotti C. Carnitine supplementation in human idiopathic asthenospermia: clinical results. Drugs Exp Clin Res 1995; 21 (4) 157-159
40 Moncada ML, Vicari E, Cimino C, Calogero AE, Mongioì A, D'Agata R. Effect of acetylcarnitine treatment in oligoasthenospermic patients. Acta Eur Fertil 1992; 23 (5) 221-224
41 Ehrenkranz RA. Vitamin E and the neonate. Am J Dis Child 1980; 134 (12) 1157-1166
42 Palamanda JR, Kehrer JP. Involvement of vitamin E and protein thiols in the inhibition of microsomal lipid peroxidation by glutathione. Lipids 1993; 28 (5) 427-431
43 Porter R, Whelan J , eds. Biology of vitamin E. Ciba Foundation Symposium 101. Proceedings of a Symposium on Biology of Vitamin E. London: Pitman Press; 1984: 1430-1439
44 Suleiman SA, Ali ME, Zaki ZM, el-Malik EM, Nasr MA. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl 1996; 17 (5) 530-537
45 Kessopoulou E, Powers HJ, Sharma KK , et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril 1995; 64 (4) 825-831
46 Dawson EB, Harris WA, Rankin WE, Charpentier LA, McGanity WJ. Effect of ascorbic acid on male fertility. Ann N Y Acad Sci 1987; 498: 312-323
47 Jacob RA, Pianalto FS, Agee RE. Cellular ascorbate depletion in healthy men. J Nutr 1992; 122 (5) 1111-1118
48 Fraga CG, Motchnik PA, Shigenaga MK, Helbock HJ, Jacob RA, Ames BN. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci U S A 1991; 88 (24) 11003-11006
49 Lewis SE, Sterling ES, Young IS, Thompson W. Comparison of individual antioxidants of sperm and seminal plasma in fertile and infertile men. Fertil Steril 1997; 67 (1) 142-147
50 Thiele JJ, Friesleben HJ, Fuchs J, Ochsendorf FR. Ascorbic acid and urate in human seminal plasma: determination and interrelationships with chemiluminescence in washed semen. Hum Reprod 1995; 10 (1) 110-115
51 Baker HW, Brindle J, Irvine DS, Aitken RJ. Protective effect of antioxidants on the impairment of sperm motility by activated polymorphonuclear leukocytes. Fertil Steril 1996; 65 (2) 411-419
52 Rolf C, Cooper TG, Yeung CH, Nieschlag E. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod 1999; 14 (4) 1028-1033
53 Giovenco P, Amodei M, Barbieri C, Fasani R, Carosi M, Dondero F. Effects of kallikrein on the male reproductive system and its use in the treatment of idiopathic oligozoospermia with impaired motility. Andrologia 1987; 19 (Spec No) 238-241
54 Moilanen J, Hovatta O. Excretion of alpha-tocopherol into human seminal plasma after oral administration. Andrologia 1995; 27 (3) 133-136
55 Ursini F, Heim S, Kiess M , et al. Dual function of the selenoprotein PHGPx during sperm maturation. Science 1999; 285 (5432) 1393-1396
56 Roveri A, Casasco A, Maiorino M, Dalan P, Calligaro A, Ursini F. Phospholipid hydroperoxide glutathione peroxidase of rat testis. Gonadotropin dependence and immunocytochemical identification. J Biol Chem 1992; 267 (9) 6142-6146
57 Alvarez JG, Storey BT. Lipid peroxidation and the reactions of superoxide and hydrogen peroxide in mouse spermatozoa. Biol Reprod 1984; 30 (4) 833-841
58 Surai PF, Blesbois E, Grasseau I , et al. Fatty acid composition, glutathione peroxidase and superoxide dismutase activity and total antioxidant activity of avian semen. Comp Biochem Physiol B Biochem Mol Biol 1998; 120 (3) 527-533
59 Wallace E, Cooper GW, Calvin HI. Effects of selenium deficiency on the shape and arrangement of rodent sperm mitochondria. Gamete Res 1983; 4: 389-399
60 Wallace E, Calvin HI, Ploetz K, Cooper GW. Functional and developmental studies on the role of selenium in spermatogenesis. In: Combs Jr GF, Spallholz JE, Levander OA, Oldfield JE, , eds. Selenium in Biology and Medicine, Part A. New York: AVI Publishing Co.; 1987. :112, 181–196
61 Watanabe T, Endo A. Effects of selenium deficiency on sperm morphology and spermatocyte chromosomes in mice. Mutat Res 1991; 262 (2) 93-99
62 Noack-Füller G, De Beer C, Seibert H. Cadmium, lead, selenium, and zinc in semen of occupationally unexposed men. Andrologia 1993; 25 (1) 7-12
63 Bleau G, Lemarbre J, Faucher G, Roberts KD, Chapdelaine A. Semen selenium and human fertility. Fertil Steril 1984; 42 (6) 890-894
64 Behne D, Gessner H, Wolters G, Brotherton J. Selenium, rubidium and zinc in human semen and semen fractions. Int J Androl 1988; 11 (5) 415-423
65 Saaranen M, Suistomaa U, Kantola M, Saarikoski S, Vanha-Perttula T. Lead, magnesium, selenium and zinc in human seminal fluid: comparison with semen parameters and fertility. Hum Reprod 1987; 2 (6) 475-479
66 Roy AC, Karunanithy R, Ratnam SS. Lack of correlation of selenium level in human semen with sperm count/motility. Arch Androl 1990; 25 (1) 59-62
67 Burton GW, Traber MG. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr 1990; 10: 357-382
68 Maiorino M, Coassin M, Roveri A, Ursini F. Microsomal lipid peroxidation: effect of vitamin E and its functional interaction with phospholipid hydroperoxide glutathione peroxidase. Lipids 1989; 24 (8) 721-726
69 Vézina D, Mauffette F, Roberts KD, Bleau G. Selenium-vitamin E supplementation in infertile men. Effects on semen parameters and micronutrient levels and distribution. Biol Trace Elem Res 1996; 53 (1–3) 65-83
70 Keskes-Ammar L, Feki-Chakroun N, Rebai T , et al. Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men. Arch Androl 2003; 49 (2) 83-94
71 Comhaire FH, El Garem Y, Mahmoud A, Eertmans F, Schoonjans F. Combined conventional/antioxidant “Astaxanthin” treatment for male infertility: a double blind, randomized trial. Asian J Androl 2005; 7 (3) 257-262
72 Klebanov GI, Kapitanov AB, Teselkin YuO , et al. The antioxidant properties of lycopene. Membr Cell Biol 1998; 12 (2) 287-300
73 Gupta NP, Kumar R. Lycopene therapy in idiopathic male infertility—a preliminary report. Int Urol Nephrol 2002; 34 (3) 369-372
74 Lenzi A, Culasso F, Gandini L, Lombardo F, Dondero F. Placebo-controlled, double-blind, cross-over trial of glutathione therapy in male infertility. Hum Reprod 1993; 8 (10) 1657-1662
75 Hansen JC, Deguchi Y. Selenium and fertility in animals and man—a review. Acta Vet Scand 1996; 37 (1) 19-30
76 Ursini F, Heim S, Kiess M , et al. Dual function of the selenoprotein PHGPx during sperm maturation. Science 1999; 285 (5432) 1393-1396
77 Gressier B, Cabanis A, Lebegue S , et al. Decrease of hypochlorous acid and hydroxyl radical generated by stimulated human neutrophils: comparison in vitro of some thiol-containing drugs. Methods Find Exp Clin Pharmacol 1994; 16 (1) 9-13
78 Erkkilä K, Hirvonen V, Wuokko E, Parvinen M, Dunkel L. N-acetyl-L-cysteine inhibits apoptosis in human male germ cells in vitro. J Clin Endocrinol Metab 1998; 83 (7) 2523-2531
79 Oeda T, Henkel R, Ohmori H, Schill WB. Scavenging effect of N-acetyl-L-cysteine against reactive oxygen species in human semen: a possible therapeutic modality for male factor infertility?. Andrologia 1997; 29 (3) 125-131
80 Comhaire FH, Christophe AB, Zalata AA, Dhooge WS, Mahmoud AM, Depuydt CE. The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. Prostaglandins Leukot Essent Fatty Acids 2000; 63 (3) 159-165
81 Safarinejad MR, Safarinejad S. Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. J Urol 2009; 181 (2) 741-751
82 Gavella M, Lipovac V. Pentoxifylline-mediated reduction of superoxide anion production by human spermatozoa. Andrologia 1992; 24 (1) 37-39
83 Gavella M, Lipovac V, Marotti T. Effect of pentoxifylline on superoxide anion production by human sperm. Int J Androl 1991; 14 (5) 320-327
84 Pang SC, Chan PJ, Lu A. Effects of pentoxifylline on sperm motility and hyperactivation in normozoospermic and normokinetic semen. Fertil Steril 1993; 60 (2) 336-343
85 Marrama P, Baraghini GF, Carani C , et al. Further studies on the effects of pentoxifylline on sperm count and sperm motility in patients with idiopathic oligo-asthenozoospermia. Andrologia 1985; 17 (6) 612-616
86 Yovich JM, Edirisinghe WR, Cummins JM, Yovich JL. Influence of pentoxifylline in severe male factor infertility. Fertil Steril 1990; 53 (4) 715-722
87 Tesarik J, Thébault A, Testart J. Effect of pentoxifylline on sperm movement characteristics in normozoospermic and asthenozoospermic specimens. Hum Reprod 1992; 7 (9) 1257-1263
88 Okada H, Tatsumi N, Kanzaki M, Fujisawa M, Arakawa S, Kamidono S. Formation of reactive oxygen species by spermatozoa from asthenospermic patients: response to treatment with pentoxifylline. J Urol 1997; 157 (6) 2140-2146
89 Chia SE, Ong CN, Chua LH, Ho LM, Tay SK. Comparison of zinc concentrations in blood and seminal plasma and the various sperm parameters between fertile and infertile men. J Androl 2000; 21 (1) 53-57
90 Omu AE, Al-Azemi MK, Kehinde EO, Anim JT, Oriowo MA, Mathew TC. Indications of the mechanisms involved in improved sperm parameters by zinc therapy. Med Princ Pract 2008; 17 (2) 108-116
91 Omu AE, Al-Qattan F, Al-Abdul-Hadi FM, Fatinikun MT, Fernandes S. Seminal immune response in infertile men with leukocytospermia: effect on antioxidant activity. Eur J Obstet Gynecol Reprod Biol 1999; 86 (2) 195-202
92 Hartoma TR, Nahoul K, Netter A. Zinc, plasma androgens and male sterility. [letter]. Lancet 1977; 2 (8048) 1125-1126
93 Tikkiwal M, Ajmera RL, Mathur NK. Effect of zinc administration on seminal zinc and fertility of oligospermic males. Indian J Physiol Pharmacol 1987; 31 (1) 30-34
94 Atig F, Raffa M, Ali HB, Abdelhamid K, Saad A, Ajina M. Altered antioxidant status and increased lipid per-oxidation in seminal plasma of tunisian infertile men. Int J Biol Sci 2012; 8 (1) 139-149
95 Wong WY, Thomas CMG, Merkus JMWM, Zielhuis GA, Steegers-Theunissen RPM. Male factor subfertility: possible causes and the impact of nutritional factors. Fertil Steril 2000; 73 (3) 435-442
96 Ebisch IM, Pierik FH, DE Jong FH, Thomas CM, Steegers-Theunissen RP. Does folic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men?. Int J Androl 2006; 29 (2) 339-345
97 Gregory J, Foster K, Tyler H, Wiseman M. The dietary and nutritional survey of British adults. In: Office of Population Censuses and Surveys. London: HMSO; 1990
98 de Bree A, van Dusseldorp M, Brouwer IA, van het Hof KH, Steegers-Theunissen RP. Folate intake in Europe: recommended, actual and desired intake. Eur J Clin Nutr 1997; 51 (10) 643-660
99 Landau B, Singer R, Klein T, Segenreich E. Folic acid levels in blood and seminal plasma of normo- and oligospermic patients prior and following folic acid treatment. Experientia 1978; 34 (10) 1301-1302
100 Ghishan FK, Said HM, Wilson PC, Murrell JE, Greene HL. Intestinal transport of zinc and folic acid: a mutual inhibitory effect. Am J Clin Nutr 1986; 43 (2) 258-262
101 Quinn PB, Cremin FM, O'Sullivan VR, Hewedi FM, Bond RJ. The influence of dietary folate supplementation on the incidence of teratogenesis in zinc-deficient rats. Br J Nutr 1990; 64 (1) 233-243
102 Favier M, Faure P, Roussel AM, Coudray C, Blache D, Favier A. Zinc deficiency and dietary folate metabolism in pregnant rats. J Trace Elem Electrolytes Health Dis 1993; 7 (1) 19-24
103 Wong WY, Merkus HM, Thomas CM, Menkveld R, Zielhuis GA, Steegers-Theunissen RP. Effects of folic acid and zinc sulfate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil Steril 2002; 77 (3) 491-498
104 Tremellen K, Miari G, Froiland D, Thompson J. A randomised control trial examining the effect of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI treatment. Aust N Z J Obstet Gynaecol 2007; 47 (3) 216-221
105 Lewin A, Lavon H. The effect of coenzyme Q10 on sperm motility and function. Mol Aspects Med 1997; 18 (Suppl): S213-S219
106 Thomas SR, Neuzil J, Stocker R. Inhibition of LDL oxidation by ubiquinol-10. A protective mechanism for coenzyme Q in atherogenesis?. Mol Aspects Med 1997; 18 (Suppl): S85-S103
107 Baker HW, Brindle J, Irvine DS, Aitken RJ. Protective effect of antioxidants on the impairment of sperm motility by activated polymorphonuclear leukocytes. Fertil Steril 1996; 65 (2) 411-419
108 Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997; 29 (3) 315-331
109 Gyllenborg J, Skakkebaek NE, Nielsen NC, Keiding N, Giwercman A. Secular and seasonal changes in semen quality among young Danish men: a statistical analysis of semen samples from 1927 donor candidates during 1977-1995. Int J Androl 1999; 22 (1) 28-36
110 Jørgensen N, Andersen AG, Eustache F , et al. Regional differences in semen quality in Europe. Hum Reprod 2001; 16 (5) 1012-1019
111 von Eckardstein S, Syska A, Gromoll J, Kamischke A, Simoni M, Nieschlag E. Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J Clin Endocrinol Metab 2001; 86 (6) 2585-2590
112 Aitken RJ, De Iuliis GN. Origins and consequences of DNA damage in male germ cells. Reprod Biomed Online 2007; 14 (6) 727-733
113 Alvarez JG. Nurture vs nature: how can we optimize sperm quality?. J Androl 2003; 24 (5) 640-648
114 Ko EY, Sabanegh Jr ES. The role of over-the-counter supplements for the treatment of male infertility—fact or fiction?. J Androl 2012; 33 (3) 292-308